A Randomized, Double-blind, Dose-adjustment, Placebo-controlled Study to Evaluate the Efficacy and Safety of Aripiprazole in Children and Adolescents With Chronic Tic Disorders or Tourette's Disorder
收藏DataCite Commons2024-12-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00006888/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this trial is to demonstrate the efficacy and safety of aripiprazole in
children and adolescents aged 6~18 years with chronic tic disorders or Tourette's disorder
提供机构：
Vivli
创建时间：
2021-04-16
